No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients.
暂无分享,去创建一个
C. Tinelli | P. Arosio | C. Torti | I. Izzo | G. Carosi | E. Quiros-Roldan | G. Lapadula | S. Costarelli | F. Castelnuovo | L. B. Gatta | G. Biasiotto
[1] J. Haines,et al. Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy , 2006, AIDS.
[2] K. Lichtenstein,et al. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] G. Ruggeri,et al. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. , 2003, Clinical chemistry.
[4] C. Arosio,et al. Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry. , 2003, Haematologica.
[5] B. Day,et al. Mitochondrial DNA Depletion, Oxidative Stress, and Mutation: Mechanisms 0f Dysfunction from Nucleoside Reverse Transcriptase Inhibitors , 2001, Laboratory Investigation.
[6] J. Arezzo,et al. Prevalence of peripheral neuropathy in injection drug users , 1999, Neurology.